These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21866366)

  • 1. Expression of MMP2 and MMP9 (gelatinases A and B) in human colon cancer cells.
    Damodharan U; Ganesan R; Radhakrishnan UC
    Appl Biochem Biotechnol; 2011 Nov; 165(5-6):1245-52. PubMed ID: 21866366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid.
    Kapral M; Wawszczyk J; Jurzak M; Dymitruk D; Weglarz L
    Acta Pol Pharm; 2010; 67(6):625-9. PubMed ID: 21229878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
    Paduch R; Kandefer-Szerszeń M; Szuster-Ciesielska A; Plewka K
    Cell Biol Int; 2010 Jan; 34(2):213-23. PubMed ID: 19947919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
    Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
    Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
    Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9.
    Buttacavoli M; Di Cara G; Roz E; Pucci-Minafra I; Feo S; Cancemi P
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of irradiation on matrix metalloproteinases, vascular endothelial growth factor and microvessel density of mice bearing Lewis lung cancer].
    Ai P; Ren ZG; Wang X; Wang SC; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):632-5. PubMed ID: 19764560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
    J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
    Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
    Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
    Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
    Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
    Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for matrix metalloproteinases in granulocyte infiltration and testicular remodelation in a seasonal breeding teleost.
    Chaves-Pozo E; Castillo-Briceño P; García-Alcázar A; Meseguer J; Mulero V; García-Ayala A
    Mol Immunol; 2008 May; 45(10):2820-30. PubMed ID: 18342940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
    Bindhu OS; Ramadas K; Sebastian P; Pillai MR
    Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis.
    Kurakata H; Oka M; Matsubara Y; Niwa T; Utsunomiya H; Fujishiro M; Miki K; Fukamachi H; Kubota S; Ichinose M
    Dev Growth Differ; 2008 Jan; 50(1):41-8. PubMed ID: 17986262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
    Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.